The 2024 program will be available in early March 2024. Please review our dynamic sessions from the 2023 BIO International Convention in Boston to see examples of topics and speakers.

BIO International Convention
Date
  • Show All
Time
  • Show All
  • Show All
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Sessions
BIO International Convention
Jump to Day
Results
Time
Monday, June 5
1:00 PM - 1:15 PM
OculoTherapy is an early-stage start-up with a novel IOP-lowering eye drop for use in patients with…
Session Room 104B
1:15 PM - 1:30 PM
NexThera Co., Ltd. is a biotech venture company that utilizes its recombinant protein-based…
Session Room 104B
1:30 PM - 1:45 PM
CXL Ophthalmics (CXLO) is developing innovative treatments for corneal diseases with the goal of…
Session Room 104B
1:45 PM - 2:00 PM
Bond Biosciences, Inc. is a privately held, clinical-stage biopharmaceutical company focused on the…
Session Room 104C
Nicox is an international ophthalmology company developing innovative therapeutics to help maintain…
Session Room 104B
Tuesday, June 6
10:30 AM - 10:45 AM
Demeetra’s proprietary gene editing technologies are being applied to unique biomanufacturing…
Session Room 104A
10:45 AM - 11:00 AM
Dignify Therapeutics is focused on restoring voluntary control of bowel and bladder function, with…
Session Room 104A
11:00 AM - 11:15 AM
Development-stage company developing first-in-class therapeutics for the treatment of chronic…
Session Room 104A
11:15 AM - 11:30 AM
Vision: Expand patient access to therapeutic biologics with oral biologics in a pill modality. …
Session Room 104A
11:45 AM - 12:00 PM
First Wave BioPharma is a clinical stage biopharmaceutical company specializing in the development…
Session Room 104A
12:00 PM - 12:15 PM
Intract is a oral biologics drug delivery platform company focusing on lower gastrointestinal tract…
Session Room 104A
12:15 PM - 12:30 PM
NIBEC is established as a spin-off venture from Seoul National University, South Korea at 2004 and…
Session Room 104A
1:45 PM - 2:00 PM
Virtual Clinical stage (Phase 3 ready) Ophthalmology focused company with a lead molecule for…
Session Room 103
2:00 PM - 4:00 PM
FELIQS, a Japanese startup company funded with a seed round of $2.5 million, develops a portfolio…
North Lobby
Wednesday, June 7
4:30 PM - 4:45 PM
FELIQS, a Japanese startup company funded with a seed round of $2.5 million, develops a portfolio…
Session Room 104C